Literature DB >> 32243609

The benefits of iron supplementation following blood donation vary with baseline iron status.

Alan E Mast1,2, Aniko Szabo3, Mars Stone4, Ritchard G Cable5, Bryan R Spencer6, Joseph E Kiss7.   

Abstract

Whole blood donation rapidly removes approximately 10% of a donor's blood volume and stimulates substantial changes in iron metabolism and erythropoiesis. We sought to identify donors who benefit from iron supplementation, describe the nature of the benefit, and define the time course for recovery from donation. Blood samples were collected over 24 weeks following whole blood donation from 193 participants, with 96 participants randomized to 37.5 mg daily oral iron. Changes in total body, red blood cell (RBC), and storage iron, hepcidin, erythropoietin, and reticulocyte count were modeled using semiparametric curves in a mixed model. and the changes were compared among six groups defined by baseline ferritin (<12; 12-50; ≥50 ng/mL) and iron supplementation. The effect of oral iron on storage and RBC iron recovery was minimal in donors with baseline ferritin ≥50 ng/mL, but sizeable when ferritin was <50 ng/mL. Iron initially absorbed went to RBC and storage iron pools when ferritin was <12 ng/mL but went mostly to RBCs when ferritin was ≥12 ng/mL. Donors with ferritin ≥12 ng/mL had a "ripple" increase in reticulocytes ~100 days after donation indicating physiological responses occur months following donation. Thus, iron supplements markedly enhance recovery from whole blood donation in donors with ferritin <50 ng/mL. However, full recovery from donation requires over 100 days when taking iron. The findings also highlight the value of the study of blood donors for understanding human hemoglobin and iron metabolism and their usefulness for future studies as additional biomarkers are discovered.
© 2020 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32243609      PMCID: PMC7393577          DOI: 10.1002/ajh.25800

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  29 in total

1.  Iron therapy in chronically fatigued, nonanemic women: a double-blind study.

Authors:  E BEUTLER; S E LARSH; C W GURNEY
Journal:  Ann Intern Med       Date:  1960-02       Impact factor: 25.391

2.  Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration.

Authors:  Pierre-Alexandre Krayenbuehl; Edouard Battegay; Christian Breymann; Joerg Furrer; Georg Schulthess
Journal:  Blood       Date:  2011-06-24       Impact factor: 22.113

3.  Effect of iron supplementation on iron stores and total body iron after whole blood donation.

Authors:  Ritchard G Cable; Donald Brambilla; Simone A Glynn; Steven Kleinman; Alan E Mast; Bryan R Spencer; Mars Stone; Joseph E Kiss
Journal:  Transfusion       Date:  2016-05-27       Impact factor: 3.157

4.  Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men.

Authors:  Mark A Roe; Rachel Collings; Jack R Dainty; Dorine W Swinkels; Susan J Fairweather-Tait
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

5.  Iron stores in male blood donors evaluated by serum ferritin.

Authors:  N Milman; M Søndergaard
Journal:  Transfusion       Date:  1984 Nov-Dec       Impact factor: 3.157

6.  The quantitative assessment of body iron.

Authors:  James D Cook; Carol H Flowers; Barry S Skikne
Journal:  Blood       Date:  2003-01-09       Impact factor: 22.113

7.  Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome.

Authors:  Barbara J Bryant; Yu Ying Yau; Sarah M Arceo; Julie A Hopkins; Susan F Leitman
Journal:  Transfusion       Date:  2013-01-10       Impact factor: 3.157

8.  Iron stores in blood donors.

Authors:  T L Simon; P J Garry; E M Hooper
Journal:  JAMA       Date:  1981 May 22-29       Impact factor: 56.272

9.  Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors.

Authors:  Emanuele Di Angelantonio; Simon G Thompson; Stephen Kaptoge; Carmel Moore; Matthew Walker; Jane Armitage; Willem H Ouwehand; David J Roberts; John Danesh
Journal:  Lancet       Date:  2017-09-21       Impact factor: 79.321

10.  Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Carmel Moore; Matthew Walker; Jane Armitage; Willem H Ouwehand; David J Roberts; John Danesh; Simon G Thompson
Journal:  Lancet Haematol       Date:  2019-08-02       Impact factor: 30.153

View more
  3 in total

1.  Oral iron and blood donation: cui bono?

Authors:  Bryan R Spencer
Journal:  Blood Transfus       Date:  2020-08-06       Impact factor: 3.443

Review 2.  Iron status of blood donors.

Authors:  Bryan R Spencer; Alan E Mast
Journal:  Curr Opin Hematol       Date:  2022-07-22       Impact factor: 3.218

3.  Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors.

Authors:  Hefei Liu; Robert T Burns; Bryan R Spencer; Grier P Page; Alan E Mast
Journal:  Transfusion       Date:  2021-04-29       Impact factor: 3.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.